Core Viewpoint - Berkshire Hathaway has re-entered the healthcare insurance sector by purchasing 5.04 million shares of UnitedHealth Group, valued at approximately $1.57 billion as of June 30, marking its first investment in this sector since exiting in 2010 [3][4]. Group 1: Berkshire Hathaway's Investment Activities - In Q2, Berkshire Hathaway significantly increased its stake in residential builders DR Horton and Lennar, while also initiating positions in safety product supplier Allegion, outdoor advertising company Lamar Advertising, and steel manufacturer Nucor, all of which saw varying degrees of stock price increases in after-hours trading [4]. - Berkshire Hathaway sold approximately $3 billion more in stocks than it bought during the April to June period, marking the 11th consecutive quarter of net selling in U.S. stocks. As of June 30, the company held $344.1 billion in cash and equivalents [5]. Group 2: Market Reactions and Historical Context - Following the announcement of Berkshire's investment in UnitedHealth, the stock price surged over 10% in after-hours trading. UnitedHealth's stock had previously declined nearly 50% this year due to rising medical costs, a U.S. Department of Justice investigation, a cyberattack last year, and the tragic death of former executive Brian Thompson [3]. - Warren Buffett had previously held UnitedHealth shares from 2006 to 2009, peaking at about 1.18 million shares, but exited due to broader pressures on the healthcare insurance sector at that time [3].

Core Viewpoint - Berkshire Hathaway, led by Warren Buffett, made significant changes in its Q2 13F filing, notably acquiring shares in UnitedHealth, which was previously considered a rumor [1][5]. Group 1: Berkshire Hathaway's Holdings - As of the end of Q2, Berkshire's long positions in U.S. stocks reached a total value of $257.5 billion [2]. - The top holdings include Apple with 280 million shares valued at approximately $57.45 billion, American Express at $48.36 billion, and Bank of America at $28.64 billion [3]. - Berkshire reduced its holdings in Apple by 20 million shares and in Bank of America by 26.3 million shares during the quarter [4]. Group 2: UnitedHealth Acquisition - Berkshire acquired 5.039 million shares of UnitedHealth, valued at $1.572 billion, marking a significant entry into the healthcare sector [5]. - Following the announcement, UnitedHealth's stock price surged over 8% in after-hours trading [5]. - The company has faced challenges, including a recent profit forecast downgrade and ongoing investigations into its billing practices [5]. Group 3: Other Investment Activities - In addition to UnitedHealth, Berkshire opened positions in Nucor, Lamar Advertising, and Allegion, while also repurchasing shares in Lennar and DR Horton [9]. - The firm increased its stakes in Chevron, Constellation Brands, and Domino's Pizza, while reducing its holdings in Charter Communications and F1 Group [11]. - Berkshire completely exited its position in T-Mobile US during this quarter [11].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against UnitedHealth Group Incorporated due to a class action complaint alleging breaches of fiduciary duties by the board of directors during the specified class period [1][4]. Company Overview - UnitedHealth is a leading American multinational health insurance and services company, consisting of two main segments: Optum and UnitedHealthcare. UnitedHealthcare is the largest insurance provider in the U.S., while Optum offers healthcare-related services such as software solutions and data analytics [2]. Acquisition and Legal Challenges - On January 6, 2021, UnitedHealth announced its agreement to acquire Change Healthcare, a healthcare technology company, to enhance its Optum business. The U.S. Department of Justice filed a lawsuit on February 24, 2022, challenging this acquisition on antitrust grounds, but the court ultimately allowed the deal to proceed, citing UnitedHealth's firewall policy [3]. Allegations of Misrepresentation - The class action complaint claims that UnitedHealth misled investors by assuring them of robust firewall processes to prevent the sharing of sensitive customer information between UnitedHealthcare and Optum. These misrepresentations allegedly led to inflated stock prices during the class period [4]. Impact of DOJ Investigation - The truth regarding the potential anti-competitive behavior emerged on February 27, 2024, when it was reported that the DOJ had reopened its investigation into UnitedHealth. Following this news, UnitedHealth's stock price fell by $27 per share, resulting in a loss of nearly $25 billion in shareholder value [5].

今年5月伯克希尔披露一季度持仓时有请求保密的仓位，此后"神秘"持仓一直在猜测之中。华尔街见闻此前提到，根据今年前两个季度的财报线索，媒体猜 测可能伯克希尔投资了一家工业企业，投资总额或接近50亿美元。 持仓文件显示，时隔半年，"股神"巴菲特领导的伯克希尔·哈撒韦公司又开始抛售头号重仓股苹果，继续减持另一重仓股美国银行。 同时，伯克希尔二季度大手笔建仓医疗保险巨头联合健康（UnitedHealth），买入股票季末价值将近16亿美元，还新进了超8亿美元的美国最大钢铁生产商纽 柯钢铁（Nucor）、将近7亿美元的美国住宅开发商Lennar（LEN）。评论称，这几只新进个股可在就是备受关注的"神秘"持仓之列。 时隔半年再次减持苹果 一年来美银持股降超40% 清仓T-Mobile 据美东时间8月14日周四披露的递交美国证监会（SEC）13F文件，伯克希尔二季度减持苹果（AAPL）2000万股，持股数较一季度环比减少6.67%，苹果持 仓占比从一季度的25.76%降至22.31%，持仓市值减少41亿美元。 这是伯克希尔半年来首次披露减持苹果。去年二季度和三季度，伯克希尔接连大幅减持苹果，减持股份幅度分别达50%和25%， ...

Core Insights - Berkshire Hathaway, led by Warren Buffett, has acquired 5 million shares in UnitedHealth Group, resulting in a 7% increase in the health insurer's stock during extended trading [1][3][5] - This investment marks a return for Buffett, who previously held approximately 1.18 million shares from 2006 to 2009 before selling his entire stake in 2010 [1][3] Company Challenges - UnitedHealth is currently facing significant challenges, including soaring medical costs, ongoing federal investigations, the aftermath of a top executive's murder, and a cyberattack that occurred last year [2][5] - The company has issued a new profit forecast that is considerably lower, anticipating billions in additional costs in the upcoming quarters [2] Stock Performance - Despite the recent investment news, UnitedHealth's shares have declined by 46% so far this year [5]

Legendary investor Warren Buffett revealed new investments in several stocks during the second quarter, with the latest 13F filing on Thursday showing what Berkshire Hathaway Inc.‘s BRK BRK portfolio looked like as of June 30, 2025. New PositionsBerkshire Hathaway unveiled several new stock positions in the second quarter, including a couple of homebuilder stocks.These were the new positions disclosed:Lennar Corporation Class A LEN: 7,048,993 sharesNucor Corporation NUE: 6,614,112 sharesUnitedHealth Group U ...

Core Insights - Berkshire Hathaway has acquired a new stake in troubled insurer UnitedHealth, building this position over two consecutive quarters [1][2] - The investment amounts to over 5 million shares, valued at approximately $1.6 billion, making it the 18th largest position in Berkshire's portfolio [2] - Berkshire's overall equity portfolio is valued at around $300 billion, suggesting that the purchase may have been driven by investment managers Todd Combs and Ted Weschler rather than Warren Buffett himself [3] - Following the announcement of this investment, UnitedHealth's stock experienced a 6% increase in extended trading [3]

风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何 意见、观点或结论是否符合其特定状况。据此投资，责任自负。 伯克希尔哈撒韦二季度减持苹果和美国银行。 新进联合健康和纽柯钢铁等，以及地产股Lennar和户外 广告公司Lamar Advertising Company。 ...

Group 1: Market Overview - Changing market themes and sector rotations have left some formerly dominant companies trailing the broader rally, raising questions about whether these "left behind" stocks represent a buying opportunity [1] - Bespoke Investment Group identified large-cap "left behind" stocks, highlighting that some well-known companies have performed poorly recently [2] Group 2: Company-Specific Insights - UnitedHealth Group, facing cost pressures and regulatory challenges, is currently trading at five-year lows, with a 57.4% decline from its 52-week high of $630.73 to $268.92, but analysts believe its market dominance and revenue potential could lead to a recovery [3][7] - Lululemon Athletica has seen a significant drop due to shifting consumer trends and increased competition, yet it retains strong brand equity and growth prospects, particularly in international and male apparel segments, suggesting a potential entry point for long-term investors [4] - The Trade Desk continues to show strong revenue growth despite challenges in the digital advertising sector, with a 61.6% decline from its 52-week high of $141.53, and analysts argue that the stock may be undervalued, presenting an opportunity for investors willing to overlook recent volatility [5][7] Group 3: Investment Strategy - Analysts suggest that some of the identified "left behind" stocks are likely to recover over the next year, emphasizing the investment strategy of buying low and selling high [6]

Group 1 - The core viewpoint is that U.S. President Trump's pharmaceutical tariffs may be implemented based on Section 232, as stated by White House advisor Navarro [1] - Following this announcement, Pfizer's stock dropped over 0.7%, while UnitedHealth fell more than 0.4%. Conversely, Amgen's stock increased by 0.6%, Johnson & Johnson rose by 0.1%, and AstraZeneca's ADR gained 0.4% [1]